Your browser doesn't support javascript.
loading
Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial.
Ihm, Sang-Hyun; Chung, Woo-Baek; Lee, Jong-Min; Hwang, Byung-Hee; Yoo, Ki-Dong; Her, Sung-Ho; Song, Woo-Hyuk; Chae, In-Ho; Park, Tae-Ho; Kim, Ju-Han; Jeon, Dong Woon; Cho, Byung-Ryul; Kang, Seung-Ho; Park, Sang-Don; Lee, Jin-Bae; Woo, Jeong-Taek; Lee, Byung-Wan; Han, Kyung-Ah; Won, Kyung-Heon; Kim, Hyo-Soo; Yu, Jae-Myung; Chung, Choon Hee; Kim, Hae-Jin; Cho, Ho-Chan; Seung, Ki-Bae.
Afiliação
  • Ihm SH; Department of Internal Medicine, Bucheon St. Mary's Hospital, Bucheon, South Korea; College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Chung WB; Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, South Korea; College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Lee JM; Department of Internal Medicine, Uijeongbu St. Mary's Hospital, Uijeongbu, South Korea; College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Hwang BH; Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, South Korea; College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Yoo KD; Department of Internal Medicine, St. Vincent's Hospital, Suwon, South Korea; College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Her SH; Department of Internal Medicine, St. Vincent's Hospital, Suwon, South Korea; College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Song WH; Department of Internal Medicine, Ansan Hospital, Korea University, Ansan, South Korea.
  • Chae IH; Department of Internal Medicine, Bundang Hospital, College of Medicine, Seoul National University, Seongnam, South Korea.
  • Park TH; Department of Internal Medicine, Dong-A University Hospital, Busan, South Korea.
  • Kim JH; Department of Internal Medicine, Chonnam National University Hospital, Gwangju, South Korea.
  • Jeon DW; Department of Internal Medicine, National Health Insurance Service, Ilsan Hospital, Goyang, South Korea.
  • Cho BR; Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University, Chuncheon, South Korea.
  • Kang SH; Department of Internal Medicine, Cheju Halla General Hospital, Jeju, South Korea.
  • Park SD; Department of Internal Medicine, Inha University Hospital, Incheon, South Korea.
  • Lee JB; Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, South Korea.
  • Woo JT; Department of Internal Medicine, Kyunghee University Medical Center, Seoul, South Korea.
  • Lee BW; Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, South Korea.
  • Han KA; Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, South Korea.
  • Won KH; Department of Internal Medicine, Seoul Medical Center, Seoul, South Korea.
  • Kim HS; Department of Internal Medicine, Seoul National University Hospital, College of Medicine, Seoul National University, Seoul, South Korea.
  • Yu JM; Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University, Seoul, South Korea.
  • Chung CH; Department of Internal Medicine, Wonju Severance Christian Hospital, Wonju, South Korea.
  • Kim HJ; Department of Internal Medicine, Ajou University Hospital, Suwon, South Korea.
  • Cho HC; Department of Internal Medicine, Dongsan Hospital, Keimyung University, Daegu, South Korea.
  • Seung KB; Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, South Korea; College of Medicine, The Catholic University of Korea, Seoul, South Korea. Electronic address: kbseung0217@gmail.com.
Clin Ther ; 42(10): 2021-2035.e3, 2020 10.
Article em En | MEDLINE | ID: mdl-32891418

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenofibrato / Quinolinas / Dislipidemias Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Clin Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenofibrato / Quinolinas / Dislipidemias Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Clin Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Coréia do Sul